Immix Biopharma Inc. (IMMX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Immix Biopharma Inc.

    NASDAQ: IMMX · Real-Time Price · USD
    2.06
    -0.04 (-1.90%)
    At close: Oct 03, 2025, 3:59 PM
    2.06
    0.00%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Immix Biopharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 17.68M 17.51M 13.44M 17.64M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 20.42K 87.23K 6.72K n/a
    Receivables
    		 1.97M 1.17M 255.71K 25.72K
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 32.27K 44.58K 78.07K n/a
    Total Current Assets
    		 20.2M 19.79M 14.9M 18.19M
    Property-Plant & Equipment
    		 2.73M 50.18K 3.56K 5.7K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 2.75M 137.41K 10.28K 5.7K
    Total Assets
    		 22.95M 19.93M 14.91M 18.19M
    Account Payables
    		 5.39M 1.43M 143.07K 142.94K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 65.22K n/a n/a 50K
    Other Current Liabilities
    		 3.17M n/a n/a n/a
    Total Current Liabilities
    		 8.69M 3.72M 1.27M 202.04K
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a 475K n/a
    Total Long-Term Liabilities
    		 1.01M n/a 475K n/a
    Total Liabilities
    		 9.7M 3.72M 1.75M 202.04K
    Total Debt
    		 1.07M n/a n/a 50K
    Book Value
    		 13.25M 16.2M 13.16M 17.99M
    Book Value Per Share
    		 0.47 0.93 0.99 1.36
    Common Stock
    		 2.76K 2K 1.4K 1.32K
    Retained Earnings
    		 -75.02M -53.41M -37.99M -29.76M
    Comprehensive Income
    		 -1.06K 134.67K 87.02K 125.41K
    Shareholders Equity
    		 13.25M 16.41M 13.16M 17.99M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist